MDMB-FUBICA

MDMB-FUBICA is a synthetic cannabinoid that is part of the cannabinoid family of research chemicals. It is a potent agonist of the CB1 receptor and CB2 receptor, which are part of the endocannabinoid system in the human body.

Chemistry

MDMB-FUBICA is a derivative of FUBICA, a synthetic cannabinoid. It is structurally related to other synthetic cannabinoids like 5F-ADB, AB-FUBINACA, and MDMB-CHMICA. The chemical formula of MDMB-FUBICA is C21H23FN2O3.

Pharmacology

MDMB-FUBICA acts as a potent agonist for the CB1 and CB2 receptors, with a higher affinity for the CB1 receptor. The CB1 and CB2 receptors are part of the endocannabinoid system, which plays a crucial role in regulating a variety of physiological and cognitive processes.

Effects

The effects of MDMB-FUBICA can vary greatly depending on the dose and the individual's tolerance to cannabinoids. Some reported effects include feelings of relaxation, altered perception, and euphoria. However, it can also cause negative effects such as anxiety, paranoia, and in some cases, hallucinations.

Legal Status

The legal status of MDMB-FUBICA varies by country. In some countries, it is classified as a controlled substance, while in others it is legal for research purposes.

Health Risks

As with all synthetic cannabinoids, there are significant health risks associated with the use of MDMB-FUBICA. These can include cardiovascular issues, respiratory problems, and in severe cases, death. It is strongly advised to use caution when using this substance.

See Also

• Synthetic cannabinoids
• Endocannabinoid system
• CB1 receptor
• CB2 receptor

This article is a stub related to pharmacology. You can help WikiMD by expanding it!